GlaxoSmithKline PLC Q4 2021 Earnings Call Transcript - Thomson StreetEvents

GlaxoSmithKline PLC Q4 2021 Earnings Call Transcript

GlaxoSmithKline PLC Q4 2021 Earnings Call Transcript - Thomson StreetEvents
GlaxoSmithKline PLC Q4 2021 Earnings Call Transcript
Published Feb 09, 2022
26 pages (17445 words) — Published Feb 09, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of GSK.L earnings conference call or presentation 9-Feb-22 2:00pm GMT

  
Brief Excerpt:

...Operator Good day, and welcome, everyone, ladies and gentlemen, to the analyst call for GSK fourth quarter 2021 results. I will now hand you over to Nick Stone, Head of Global Investor Relations, who will introduce today's session. Please proceed. Nick Stone Thank you, operator. Hello, everyone. This is Nick, obviously, the operator's just mentioned. Welcome to our full year and Q4 2021 conference call and webcast for investors and analysts. The presentation was posted to gsk.com and it was also sent out by e-mail to our distribution list earlier today....

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
GlaxoSmithKline PLC
Ticker
GSK.L
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Kerry Ann Holford - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Just a follow-up on RSV on older adults, please. How you mentioned targeting the June ASB meeting. So I guess you're working on the assumption of a launch next year. And I would just like to understand what gives you the confidence that the regulators accept it to package from 1 RSV-C only, given your competitor studies will continue further? Is there a risk that the regulators want to see more data across more seasons before moving to approve a vaccine here? And do you think that decision will ultimately be influenced by the clinical efficacy you and your peers deliver?

Table Of Contents

GlaxoSmithKline PLC Q1 2022 Earnings Call Transcript – 2022-04-27 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 27-Apr-22 11:00am GMT

GlaxoSmithKline PLC at UBS Global Consumer & Retail Conference (Virtual) Transcript – 2022-03-09 – US$ 54.00 – Edited Transcript of GSK.L presentation 9-Mar-22 4:00pm GMT

GlaxoSmithKline PLC at Cowen Health Care Conference (Virtual) Transcript – 2022-03-07 – US$ 54.00 – Edited Transcript of GSK.L presentation 7-Mar-22 4:10pm GMT

GlaxoSmithKline PLC and HALEON PLC Consumer Healthcare Capital Markets Day Transcript – 2022-02-28 – US$ 54.00 – Edited Transcript of GSK.L corporate analyst meeting</ 28-Feb-22 12:30pm GMT

GlaxoSmithKline PLC to Discuss About Investing in Healthcare Innovations: A Case Study of Multi-stakelholder Capitalism in Practice Call Transcript – 2022-02-10 – US$ 54.00 – Edited Transcript of GSK.L conference call or presentation 10-Feb-22 1:00pm GMT

GlaxoSmithKline PLC at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-11 – US$ 54.00 – Edited Transcript of GSK.L presentation 11-Jan-22 12:30pm GMT

GlaxoSmithKline PLC at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript – 2022-01-06 – US$ 54.00 – Edited Transcript of GSK.L presentation 6-Jan-22 1:00pm GMT

GlaxoSmithKline PLC Meet GSK Management: Getting Ahead of HIV Transcript – 2021-11-29 – US$ 54.00 – Edited Transcript of GSK.L corporate analyst meeting</ 29-Nov-21 3:00pm GMT

GlaxoSmithKline PLC Investor Science Event: ASN Kidney Week Transcript – 2021-11-07 – US$ 54.00 – Edited Transcript of GSK.L corporate analyst meeting</ 7-Nov-21 5:00pm GMT

GlaxoSmithKline PLC Q3 2021 Earnings Call Transcript – 2021-10-27 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 27-Oct-21 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "GlaxoSmithKline PLC Q4 2021 Earnings Call Transcript" Feb 09, 2022. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-GlaxoSmithKline-PLC-Earnings-Call-T15090392>
  
APA:
Thomson StreetEvents. (2022). GlaxoSmithKline PLC Q4 2021 Earnings Call Transcript Feb 09, 2022. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-GlaxoSmithKline-PLC-Earnings-Call-T15090392>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.